- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Pharmaids Pharmaceuticals confirmed its adherence to securities dematerialization procedures for the quarter ended September 30. The company's Registrar and Share Transfer Agent certified that shares received for dematerialization were verified, cancelled, and records with depositories (NSDL and CDSL) were updated within 15 days. This ensures efficient processing of shareholder requests for converting physical shares into electronic form, maintaining accurate ownership records, and upholding good corporate governance standards for investors.